Stem-cell leap defied Japanese norms
It's not surprising that last week Haruko Obokata issued a plea for privacy. On Jan. 29 she published a scientific paper on stem cells that could revolutionize medicine, and overnight the researcher based at the Riken Center for Developmental Biology (CDB) in Kobe became ...
Yamanaka takes issue with claims STAP cells are safer than iPS option
Nobel Prize-winning scientist Shinya Yamanaka, facing reporters in Kyoto, decried "three misconceptions" about the induced pluripotent stem, or iPS, cells that he developed in relation to STAP cells were recently unveiled. The Kyoto University professor said Monday that one of the misconceptions is that iPS ...
The Kyoto University Center for iPS Cell Research and Application has started creating induced pluripotent stem cells (iPS cells) for stockpiling for future use in regenerative medicine and clinical research, officials said. The cell stockpiling project is being led by the center's director, Shinya Yamanaka, ...
World's first iPS clinical research for retina regeneration begins
The world's first clinical research using induced pluripotent stem cells, known as iPS cells, for the regeneration of retina begins Thursday, according to a Japanese team of researchers. The state-backed scientific research institute Riken, based in Wako, Saitama Prefecture, and the Foundation for Biomedical Research ...
A Kyoto University research team is to be applauded for getting the go-ahead to test the safety of an iPS transplant procedure on six patients with an age-related eye disease.
Japan's Institute of Physical and Chemical Research asks the health ministry for permission to do a clinical study using iPS cells to treat eye disease.
A U.S. foundation sponsored by top U.S. business executives said Wednesday it has selected 11 researchers, including Japanese stem cell researcher and Nobel laureate Shinya Yamanaka, as inaugural winners of the newly launched Breakthrough Prize in Life Sciences for their past achievements in the ...
Kyoto University professor Shinya Yamanaka has revealed that a project to stockpile artificially derived stem cells for clinical research will start in early February. The project is intended to create induced pluripotent stem cells from the blood of people with rare cell forms, known as ...
